184 related articles for article (PubMed ID: 18358497)
1. Agonist-specific down regulation of mu-opioid receptors: Different cellular pathways are activated by different opioid agonists.
Binyaminy B; Gafni M; Shapira M; Sarne Y
Life Sci; 2008 Apr; 82(15-16):831-9. PubMed ID: 18358497
[TBL] [Abstract][Full Text] [Related]
2. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
3. Membrane-delimited proteolytic regulation of opioid receptors.
Kaplan E; Binyaminy B; Gafni M; Keren O; Sarne Y
Brain Res; 2011 Apr; 1386():25-34. PubMed ID: 21338590
[TBL] [Abstract][Full Text] [Related]
4. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
Belcheva MM; Barg J; Gloeckner C; Gao XM; Chuang DM; Coscia CJ
Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
6. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
7. Opioid-induced regulation of gene expression in PC12 cells stably transfected with mu-opioid receptor.
Zarnegar P; Persson AI; Ming Y; Terenius L
Neurosci Lett; 2006 Apr; 396(3):197-201. PubMed ID: 16377088
[TBL] [Abstract][Full Text] [Related]
8. Role of cAMP-dependent protein kinase (PKA) in opioid agonist-induced mu-opioid receptor downregulation and tolerance in mice.
Shen J; Benedict Gomes A; Gallagher A; Stafford K; Yoburn BC
Synapse; 2000 Dec; 38(3):322-7. PubMed ID: 11020235
[TBL] [Abstract][Full Text] [Related]
9. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
[TBL] [Abstract][Full Text] [Related]
10. Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.
Wang Q; Traynor JR
J Biol Chem; 2011 Mar; 286(10):7854-7864. PubMed ID: 21209077
[TBL] [Abstract][Full Text] [Related]
11. Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons.
Koyama S; Akaike N
Neurosci Res; 2008 Jan; 60(1):22-8. PubMed ID: 17976846
[TBL] [Abstract][Full Text] [Related]
12. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
Kivell BM; Day DJ; McDonald FJ; Miller JH
Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
[TBL] [Abstract][Full Text] [Related]
13. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
[TBL] [Abstract][Full Text] [Related]
14. Internalization and recycling of human mu opioid receptors expressed in Sf9 insect cells.
Chen LE; Gao C; Chen J; Xu XJ; Zhou DH; Chi ZQ
Life Sci; 2003 May; 73(1):115-28. PubMed ID: 12726892
[TBL] [Abstract][Full Text] [Related]
15. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
[TBL] [Abstract][Full Text] [Related]
16. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
[TBL] [Abstract][Full Text] [Related]
17. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC.
Kramer HK; Simon EJ
J Neurochem; 1999 Feb; 72(2):594-604. PubMed ID: 9930731
[TBL] [Abstract][Full Text] [Related]
18. The response of phospholipase C/protein kinase C and adenylyl cyclase/protein kinase A pathways in porcine theca interna cells to opioid agonist FK 33-824.
Kaminski T
Domest Anim Endocrinol; 2004 Nov; 27(4):379-96. PubMed ID: 15519041
[TBL] [Abstract][Full Text] [Related]
19. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype.
Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ
Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732
[TBL] [Abstract][Full Text] [Related]
20. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
